Analyse OptimizeRx Corporation (OPRX) — Kairos Score 62/100

À propos de OptimizeRx Corporation

OptimizeRx Corporation operates as a digital healthcare technology company. It offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers' target consumers; banner messages, including brand messaging, therapeutic support messaging, affordability messaging, limited distribution drug information, and patient support program messaging through healthcare professionals; and media execution solutions, which deliver messages through consumer omnichannel network, including through programmatic display, programmatic connected television/over-the-top, programmatic social media, addressable television, digital out-of-home, programmatic audio, and email/direct mail. The company also offers pharmacy alerts, which flag pharmacies that have prescription medications in stock; and financial messaging solutions, which provide prescribers visibility to branded copay offers for patients directly within electronic health record systems and ePrescribing platforms. The company was founded in 2006 and is headquartered in Waltham, Massachusetts.

Informations clés

🕴️ Activité des initiés (90 jours)

9 transactions — 0 achats et 0 ventes déclarés par les dirigeants de OptimizeRx Corporation.

🏦 Hedge Funds

15 fonds institutionnels déclarent une position sur OPRX dans leur dernière déclaration trimestrielle SEC.

📰 Actualités récentes

15 articles récents sur OPRX.

• OptimizeRx Partners With The Trade Desk To Widen Its Healthcare Ad Network
• OptimizeRx Brings Net New Authenticated HCP Reach to The Trade Desk Through OpenPath

🧠 Ce qui fait Kairos Insider

Au-dela des donnees brutes, nous agregeons et scoring tout le signal smart money pour vous donner une vue unique.